Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check2 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and the previous entry v3.4.3 has been removed. No study data or results are changed.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the study record history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.4.2 was added to the history, and the funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.9%

- Check45 days agoChange DetectedA site-wide government funding notice has been added to the top of the page, and the revision history now shows a new Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check52 days agoChange DetectedThe new version adds a 'Show glossary' option and color-coded change indicators (green for additions, red for deletions) with notes like 'Data that is changed in the study record is color coded' and 'Revision: v3.4.0'. Older entries such as 'No FEAR Act data' and 'Revision: v3.3.4' were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check66 days agoChange DetectedThe history shows a new revision (v3.3.4) added and v3.3.3 removed from the study's record history; these are minor metadata updates to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.